You are here

Neil Jones

Associate Director, Target Validation & Disease Positioning

A cell biologist by training, Neil leads a group focused on target validation and disease positioning. Since joining CRUK-TDL (then CRT-DL) in 2008, he has worked on a number of projects and led a multi-project cancer metabolism alliance with AstraZeneca. Neil has worked in a number of areas of cancer biology including cell signalling, metastasis, metabolism and epigenetics and has a strong background in target identification and validation. Prior to joining CRT-DL, Neil conducted postdoctoral research at the Institute of Cancer Research. Neil obtained his first degree in Medical Biochemistry from the University of Birmingham and a PhD in biochemistry from the University of Southampton.